PSA Screening of African-American Men in The San Francisco Area
Further study details as provided by National Cancer Institute (NCI):
undefined
undefined
undefined undefined
Primary Outcome Measures:
Degree to which patients who are being screened for prostate cancer have been previously screened [ Designated as safety issue: No ]
Estimated Enrollment:
175
Study Start Date:
August 2002
Estimated Primary Completion Date:
August 2022 (Final data collection date for primary outcome measure)
Detailed Description:
OBJECTIVES:
Primary
To determine the degree to which patients who are being screened for prostate cancer have been previously screened.
OUTLINE: Participants complete questions on a survey about prior prostate-specific antigen (PSA) blood tests done for the purpose of screening or prostate cancer and are asked about their pastor, church, and how they heard about the SELECT study to determine whether the degree to which African American men in a church-going population have been previously screened.
Eligibility
Ages Eligible for Study:
35 Years and older
Genders Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Criteria
DISEASE CHARACTERISTICS:
Meets all of the following criteria:
African-American Male
Age 35 years or older
Attend church on a regular basis
Resides in the San Francisco area
PATIENT CHARACTERISTICS:
Not specified
PRIOR CONCURRENT THERAPY:
Not specified
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00702104 Locations
United States, California
UCSF Helen Diller Family Comprehensive Cancer Center
Recruiting
San Francisco, California, United States, 94115
Contact: Clinical Trials Office - UCSF Helen Diller Family Comprehensi 877-827-3222
Sponsors and Collaborators
UCSF Helen Diller Family Comprehensive Cancer Center
